Cite
Melani C, Wilson WH. Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure. Leuk Lymphoma. 2021;1-3doi: 10.1080/10428194.2021.2002323.
Melani, C., & Wilson, W. H. (2021). Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure. Leukemia & lymphoma, 1-3. https://doi.org/10.1080/10428194.2021.2002323
Melani, Christopher, and Wilson, Wyndham H. "Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure." Leukemia & lymphoma vol. (2021): 1-3. doi: https://doi.org/10.1080/10428194.2021.2002323
Melani C, Wilson WH. Front-Line treatment of diffuse large B-Cell lymphoma in patients with cardiovascular comorbidities; omission of anthracycline reduces cure. Leuk Lymphoma. 2021 Nov 11;1-3. doi: 10.1080/10428194.2021.2002323. Epub 2021 Nov 11. PMID: 34763592.
Copy
Download .nbib
